Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cb03ff309c31e766cf428b88c1dd9a6 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 |
filingDate |
2014-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3ed51b58d121c176e9b3f02ea97f555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52ea3a74f022601b1966605e316ed668 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efa828cfa9252c6c27c872c3df7438e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2609d1963a1e0120c86ee49991fd82d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_139ef3f8eb51fc2f875c4bcdea7d73d6 |
publicationDate |
2015-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2014280913-A1 |
titleOfInvention |
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety |
abstract |
Abstract The invention provides a compound of Formula I: Pharmaceutical compositions comprising such compounds and the use of such compounds in the treatment of phosphoinositide 3-kinase related diseases and disorders such as cancer. The instant application further relates to the treatment of histone deacetylase related disorders and diseases related to both histone deacetylase and phosphoinositide 3-kinase. |
priorityDate |
2011-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |